Term Note Payable |
6 Months Ended |
---|---|
Sep. 30, 2019 | |
Term Note Payable | |
Term Note Payable |
11. Term Note Payable
On February 4, 2019 (the “Closing Date”), we entered into a Note Purchase Agreement (the “Note Purchase Agreement”), by and among us, certain subsidiaries of us party thereto as guarantors, Goldman Sachs Specialty Lending Holdings, Inc. and any other purchasers party thereto from time to time (collectively, the “Purchaser”) and Goldman Sachs Specialty Lending Holdings, Inc. Under the Note Purchase Agreement, we sold to the Purchaser $30.0 million aggregate principal amount of senior secured notes (the “Notes”), which bear interest at a rate of 13.0% per annum and payable quarterly on March 31, June 30, September 30 and December 31 of each year until maturity. The entire principal amount of the Notes is due and payable on February 4, 2022 (the “Maturity Date”). The Notes do not amortize and the entire principal balance is due in a single payment on the Maturity Date. As of September 30, 2019, $30.0 million in borrowings were outstanding under the three-year term note. Obligations under the Note Purchase Agreement are secured by all of our assets, including intellectual property and general intangibles. The Note Purchase Agreement contains customary covenants, including, among others, covenants that restrict our ability to incur debt, grant liens, make certain investments and acquisitions, pay dividends, repurchase equity interests, repay certain debt, amend certain contracts, enter into affiliate transactions and asset sales or make certain equity issuances (including equity issuances that would cause an ownership change within the meaning of Section 382 of the Internal Revenue Code), and covenants that require us to, among other things, provide annual, quarterly and monthly financial statements, together with related compliance certificates, maintain its property in good repair, maintain insurance and comply with applicable laws. The financial covenants of the Note Purchase Agreement require the Company not to exceed specified levels of Adjusted EBITDA losses relative to its financial model, beginning with the fiscal quarter ending September 30, 2020. Additionally, we shall not permit our minimum consolidated liquidity, which consists of our cash and cash equivalents, to be less than $12.0 million through February 4, 2020, and $9.0 million thereafter. As of September 30, 2019, the Company was in compliance with the covenants contained in the Note Purchase Agreement. The three-year term note has been recorded net of a discount based on the fair value of the associated common stock warrants and debt issuance costs totaling $2.3 million. Amortization of the debt discount and debt issuance costs was $0.3 million and $0.6 million for the three and six months ended September 30, 2019, respectively, based on an effective interest rate, and has been recorded as interest expense in the condensed consolidated statements of operations. Interest expense related to the term note payable during the three months ended September 30, 2019 was $1.3 million, which includes $0.3 million in amortization of debt issuance costs. Interest expense payable during the six months ended September 30, 2019 was $2.6 million, which includes $0.6 million in amortization of debt issuance costs. When we entered into the Note Purchase Agreement the existing credit facility with Bridge Bank was paid in full. As such, there was no interest expense related to the credit facility during the six months ended September 30, 2019. Interest expense related to the credit facility during the three and six months ended September 30, 2018 was $0.2 million and $0.3 million, which includes $46,900 and $0.1 million in amortization of debt issuance costs, respectively. |